11. Farbstein D., Kozak-Blickstein A., Levy A. P. Antioxidant Vitamins and Their Use in Preventing Cardiovascular Disease // Molecules, 2010. Vol. 15, N. 11. P. 8098–8110; Aggarwal B. B., Sundarum C., Prasad S., Kannappan R. Tocotrienols, the Vitamin E of the 21st Century: Its Potential against Cancer and Other Chronic Diseases // Biochemical Pharmacology, 2010. Vol. 80, N. 11. P. 1613–1631.

12. Hennekens C. H., Gaziano J. M., Manson J. E., Buring J. E. Antioxidant Vitamin-Cardiovascular Disease Hypothesis Is Still Promising, But Still Unproven: The Need for Randomized Trials // American Journal of Clinical Nutrition, 1995. Vol. 62. P. 1377S–1380S.

13. Pearce B. C., Parker R. A., Deason M. E. et al. Hypercholesterolemic Activity of Synthetic and Natural Tocotrienols // Journal of Medicinal Chemistry, 1992. Vol. 35, N. 20. P. 3595–3606.

14. Pearce B. C., Parker R. A., Deason M. E. et al. Hypercholesterolemic Activity of Synthetic and Natural Tocotrienols // Journal of Medicinal Chemistry, 1992. Vol. 35, N. 20. P. 3595–3606.

15. Augustyniak A. et al. Natural and Synthetic Antioxidants: An Updated Overview // Free Radical Research, 2010. Vol. 44, N. 10. P. 1216–1262.

16. Rimm E. B., Stampfer M. J., Ascherio A. et al. Vitamin E Consumption and the Risk of Coronary Heart Disease in Men // New England Journal of Medicine, 1993, May 20. Vol. 328, N. 20. P. 1450–1456; Stampfer M. J., Hennekens C. H., Manson J. E. et al. Vitamin E Consumption and the Risk of Coronary Disease in Women // New England Journal of Medicine, 1993, May 20. Vol. 328, N. 20. P. 1444–1449.

17. Sesso et al. Vitamins E and C; Lee I. M., Cook N. R., Gaziano J. M. et al. Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer: The Women’s Health Study: A Randomized Controlled Trial // Journal of the American Medical Association, 2005. Vol. 294, N. 1. P. 56–65; Lonn E. et al. Effects of Long-Term Vitamin E Supplementation on Cardiovascular Events and Cancer: A Randomized Controlled Trial // Journal of the American Medical Association, 2005. Vol. 293, N. 11. P. 1338–1347; Vivekananthan D. P., Penn M. S., S. K. Sapp et al. Use of Antioxidant Vitamins for the Prevention of Cardiovascular Disease: Meta-analysis of Randomised Trials // Lancet, 2003, June 14. Vol. 361, No. 9374. P. 2017–2023.

18. Lee et al. Vitamin E in the Primary Prevention; Lonn et al. Effects of Long-Term Vitamin E; Kirsh V. A. et al. Supplemental and Dietary Vitamin E, Beta-Carotene, and Vitamin C Intakes and Prostate Cancer Risk // Journal of the National Cancer Institute, 2006, February 15. Vol. 98, N. 4. P. 245–254; Lippman S. M. et al. Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT) // Journal of the American Medical Association, 2009, January 7. Vol. 301, N. 1. P. 39–51.

19. Lippman et al. Effect of Selenium; Liu S., Lee I. M., Song Y. et al. Vitamin E and Risk of Type 2 Diabetes in the Women’s Health Study Randomized Controlled Trial // Diabetes, 2006, October. Vol. 55, N. 10. P. 2856–2862.

20. Christen W. G., Glynn R. J., Sesso H. D. et al. Age-Related Cataract in a Randomized Trial of Vitamins E and C in Men // Archives of Ophthalmology, 2010, November. Vol. 128, N. 11. P. 1397–1405.

21. Tsiligianni I. G., van der Molen T. A Systematic Review of the Role of Vitamin Insufficiencies and Supplementation in COPD // Respiratory Research, 2010, December 6. Vol. 11. P. 171.

22. Bjelakovic G., Nikolova D., Gluud L. L. et al. Antioxidant Supplements for Prevention of Mortality in Healthy Participants and Patients with Various Diseases // Cochrane Database of Systematic Reviews, 2012. Vol. 3.

23. Dotan Y., Lichtenberg D., Pinchuk I. No Evidence Supports Vitamin E Indiscriminate Supplementation // Biofactors, 2009. Vol. 35, N. 6. P. 469–473; Blumberg J., Frei B. Why Clinical Trials of Vitamin E and Cardiovascular Diseases May Be Fatally Flawed // Free Radical Biology & Medicine, 2007. Vol. 43, N. 10. P. 1374–1376.

24. Aggarwal et al. Tocotrienols.

25. Farbstein et al. Antioxidant Vitamins.

26. Lonn et al. Effects of Long-Term Vitamin E.

27. Bjelakovic et al. Mortality in Randomized Trials; Miller et al. Meta-analysis.

28. Ebbesson S. O. et al. Fatty Acid Consumption and Metabolic Syndrome Components: The GOCADAN Study // Journal of the Cardiometabolic Syndrome, 2007. Vol. 2, N. 4. P. 244–249.

29. Lopez-Garcia E., Schulze M. B., Manson J. E. et al. Consumption of (n-3) Fatty Acids Is Related to Plasma Biomarkers of Inflammation and Endothelial Activation in Women // Journal of Nutrition, 2004. Vol. 134, N. 7. P. 1806–1811; Deckelbaum R. J., Worgall T. S., Seo T. n-3 Fatty Acids and Gene Expression // Suppl., American Journal of Clinical Nutrition, 2006. Vol. 83, N. 6. P. 1520S–1525S.

30. Kaushik S. V., Mozaffarian D., Spiegelman D. et al. Long-Chain Omega-3 Fatty Acids, Fish Intake, and the Risk of Type 2 Diabetes Mellitus // American Journal of Clinical Nutrition, 2009. Vol. 90, N. 3. P. 613–620.

31. Hooper L. et al. Risks and Benefits of Omega 3 Fats for Mortality, Cardiovascular Disease, and Cancer: Systematic Review // BMJ, 2006. Vol. 332, N. 7544. P. 752–760.

32. Kaushik et al. Long-Chain Omega-3 Fatty Acids.

33. Foote C. S., Chang Y. C., Denny R. W. Chemistry of Singlet Oxygen. X. Carotenoid Quenching Parallels Biological Protection // Journal of the American Chemical Society, 1970. Vol. 92, N. 17. P. 5216–5218; Packer J. E., Mahood J. S., Mora-Arellano V. O. et al. Free Radicals and Singlet Oxygen Scavengers: Reaction of a Peroxy-radical with -carotene, Diphenyl Furan and 1,4-diazobicyclo(2,2,2)-octane // Biochemical and Biophysical Research Communications, 1981. Vol. 98, N. 4. P. 901–906.